Hallucinogen binding to dopamine/neuroleptic receptors.
D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism*; D001058:Apomorphine / Q000378:metabolism; D002417:Cattle; D002421:Caudate Nucleus / Q000378:metabolism; D003986:Dibenzocycloheptenes / Q000378:metabolism; D006213:Hallucinogens / Q000378:metabolism*; D006220:Haloperidol / Q000378:metabolism; D066298:In Vitro Techniques; D011954:Receptors, Dopamine / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*
D014150:Antipsychotic Agents; D003986:Dibenzocycloheptenes; D006213:Hallucinogens; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D006220:Haloperidol; D001058:Apomorphine